Entra Lands Series A Venture Capital Funding
Wednesday, January 07, 2009 5:42:00 AM PDT | VentureDeal Staff
Waltham, Massachusetts -- Stealthy Entra Pharmaceuticals has secured $4.2 million in its first round of venture capital financing, according to a report in VentureWire.
Entra is developing unspecified pharmaceutical drug delivery technologies.
Investors in the round were not disclosed. The report also did not disclose how the funding proceeds would be used.
Email Page | Print Page